A comparison of osmotic dilators, Lamicel and Dilapan, and a prostaglandin E1 analogue, gemeprost, for ripening the cervix before legal abortion
| Autor: | I. M. Golland, C. A. Vaughan-williams, M. Elstein |
|---|---|
| Rok vydání: | 1989 |
| Předmět: |
Physiology
Population Population Dynamics Statistics as Topic Urogenital System Endocrine System Cervix Uteri chemistry.chemical_compound Gemeprost medicine Humans Genitalia Prostaglandin E1 education Birth Rate Cervix Biology Contraception Behavior Demography education.field_of_study business.industry Genitalia.female Research Uterus Obstetrics and Gynecology Abortion Induced Genitalia Female Patient Acceptance of Health Care Parity medicine.anatomical_structure Contraception Fertility chemistry Evaluation Studies as Topic Anesthesia Family Planning Services Weeks pregnant Prostaglandins Legal abortion Cervical dilatation business medicine.drug |
| Zdroj: | Journal of obstetrics and gynaecology. 9(3) |
| Popis: | SummarySummarySixty-six primigravid women were allocated at random to receive either intravaginal application of the prostaglandin E, analogue, gemeprost, or intracervical insertion of one of two osmotic dilators, 'Lamicel' or 'Dilapan', 3 hours before legal abortion at 7 to 14 weeks pregnant. Insertion of the dilators was not possible in five patients. All three methods were otherwise equally effective in achieving cervical dilatation and there was no difference in the need for or resistance to further dilatation between the three groups. Gemeprost was the most easily administered, and would be the most appropriate for routine pre-operative use. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|